Syngene announces that its new range of G:BOX Chemi advanced multi-application image analysers can be used for imaging with infra red (IR) LI-COR IRDye® dyes, making it easier to detect and quantify different types of proteins on multiplex Western blots.

L-DOS47 combines Helix's DOS47 technology with NRC's highly specialized camelid-derived single domain antibody to identify a unique CEACAM6 antigenic site associated with NSCLC cells.

DiaMedica announces antihypertensive results with antibody DM-204.

L-DOS47 is intended to offer an innovative approach to the first-line treatment of inoperable, locally advanced, recurrent or metastatic, non-small cell lung cancer.

Chembio developed a prototype of the test in the Phase I work in collaboration with the Infectious Disease Research Institute.

U.S. patent and trademark office has issued an official notice of allowance for a new U.S. patent specific to the DPX-0907 therapeutic cancer vaccine.

The data for DV-601 has reported in a poster session Saturday, February 19 at the 21st Conference of the APASL 2011 in Bangkok, Thailand.

The symposium offers education, instruction, and insight on new therapies and treatments for posterior-segment disease and disorders, as well as valuable networking opportunities.

DSMB established for Dynavax's two ongoing Phase 3 trials for HEPLISAV™ has completed planned safety assessments.

The data is reported in Geneva, Switzerland at the world health organization 7th meeting on evaluation of pandemic influenza prototype vaccines.